Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | 1,673.50 | 861.90 | 202.20 | 579.60 |
Depreciation/ Depletion | 186.80 | 163.80 | 142.60 | 116.90 |
Non- Cash Items | -53.00 | -61.80 | -18.70 | -54.80 |
Changesin Working Capital | -595.70 | -114.80 | -279.60 | -342.90 |
Cashfrom Operating Activities | 1,211.60 | 849.10 | 46.50 | 298.80 |
Capital Expenditures | -339.40 | -146.30 | -232.80 | -254.60 |
Other Investing Cash Flow Items Total | -693.30 | -330.80 | 227.50 | 151.30 |
Cashfrom Investing Activities | -1,032.70 | -477.10 | -5.30 | -103.30 |
Financing Cash Flow Items | -18.10 | -14.20 | -18.80 | -22.30 |
Total Cash Dividends Paid | -170.80 | -100.40 | -82.20 | -113.90 |
Issuance( Retirement)of Stock Net | -253.70 | -7.40 | - | 0.10 |
Issuance( Retirement)of Debt Net | 195.70 | -241.00 | 135.80 | -49.60 |
Cashfrom Financing Activities | -246.90 | -363.00 | 34.80 | -185.70 |
Foreign Exchange Effects | 6.50 | 11.80 | 9.30 | -3.80 |
Net Changein Cash | -61.50 | 20.80 | 85.30 | 6.00 |
Cash Interest Paid | 18.10 | 14.20 | 17.00 | 12.80 |
Cash Taxes Paid | 286.30 | 177.50 | 48.20 | 130.00 |
Natco Pharma Dividend Natco Pharma Bonus Natco Pharma News Natco Pharma AGM Natco Pharma Rights Natco Pharma Splits Natco Pharma Board Meetings Natco Pharma Key Metrics Natco Pharma Shareholdings Natco Pharma Profit Loss Natco Pharma Balance Sheet Natco Pharma Q1 Results Natco Pharma Q2 Results Natco Pharma Q3 Results Natco Pharma Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks